Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors
Aidan Ingham, Luke Wharton, Helena Koniar, Helen Merkens, Scott McNeil, Sathiya Sekar, Maryam Osooly, Cristina Rodríguez‐Rodríguez, François Bénard, Paul Schaffer, Hua Yang
Topics & Concepts
Neuroendocrine tumorsAlpha (finance)MedicineInternal medicineSurgeryPatient satisfactionConstruct validityRadiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research AdvancesPeptidase Inhibition and Analysis